Zimbabwe has declined a significant US health deal worth 367 million US dollars (£272m) over five years because of the United States' demand for sensitive data.
This move came to light following a official document dated December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the agreement was "skewed".
An official spokesman later explained that the US was seeking genetic material for scientific study and commercial purposes while refused to guarantee the benefits from future medical innovations.
"We must now begin the challenging and unfortunate process of winding down our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had provided more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged continued dialogue to find a deal suitable to all parties so the nation's critical HIV programme can continue.
Wider Implications
Zimbabwe's decision comes after a comparable case in neighbouring Kenya, where a court halted a similar deal with the US following legal challenges were filed about the security of Kenyans' medical information.
Since returning to the presidency recently, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
The agency had administered assistance for the American government, but Trump stated its expenditure was "inefficient" and his government was seeking direct bilateral deals to enhance openness and responsibility.
According to statements, Sixteen nations in Africa have so far agreed to similar agreements, representing over $18.3bn of fresh investment.
Specifics of the Declined Deal
The money for Zimbabwe would have funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership would have delivered significant advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving HIV treatment via US-supported programmes," the Ambassador said.
However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to surrender its genetic material and health information over an extended period, with no corresponding promise of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.
"Effectively, our nation would supply the basic resources for scientific discovery with no certainty that the final treatments would be accessible to our people if a future health crisis emerge."
National Interest and Global Health
He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were upending structures previously set up through the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage future pandemics.
"This framework is designed to ensure that when a country provides its data, the benefits – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to develop them."
The government's concerns regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We welcome ongoing discussions with our US partners on how subsequent co-operation might be structured in a way that respects the sovereignty and interests of each country."
Health Experts Response
Medical experts expressed it acknowledged the official position, but urged that negotiations must proceed since a large portion of the country's HIV programmes relied on international support.
"Where specific concerns arise, including those relating to data governance or agreement terms, these can frequently be addressed via technical clarification and mutually agreed protections," it said.
The situation emphasises the ongoing tensions between accepting much-needed international aid and safeguarding national sovereignty in an ever more interconnected world.